Literature DB >> 24379593

Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy.

Jun-Jie Xiong1, Quentin M Nunes1, Wei Huang1, Samir Pathak1, Ai-Lin Wei1, Chun-Lu Tan1, Xu-Bao Liu1.   

Abstract

AIM: To investigate the effect of preoperative biliary drainage (PBD) in jaundiced patients with hilar cholangiocarcinoma (HCCA) undergoing major liver resections.
METHODS: An observational study was carried out by reviewing a prospectively maintained database of HCCA patients who underwent major liver resection for curative therapy from January 2002 to December 2012. Patients were divided into two groups based on whether PBD was performed: a drained group and an undrained group. Patient baseline characteristics, preoperative factors, perioperative and short-term postoperative outcomes were compared between the two groups. Risk factors for postoperative complications were also analyzed by logistic regression test with calculating OR and 95%CI.
RESULTS: In total, 78 jaundiced patients with HCCA underwent major liver resection: 32 had PBD prior to operation while 46 did not have PBD. The two groups were comparable with respect to age, sex, body mass index and co-morbidities. Furthermore, there was no significant difference in the total bilirubin (TBIL) levels between the drained group and the undrained group at admission (294.2 ± 135.7 vs 254.0 ± 63.5, P = 0.126). PBD significantly improved liver function, reducing not only the bilirubin levels but also other liver enzymes. The preoperative TBIL level was significantly lower in the drained group as compared to the undrained group (108.1 ± 60.6 vs 265.7 ± 69.1, P = 0.000). The rate of overall postoperative complications (53.1% vs 58.7%, P = 0.626), reoperation rate (6.3% vs 6.5%, P = 1.000), postoperative hospital stay (16.5 vs 15.0, P = 0.221) and mortality (9.4% vs 4.3%, P = 0.673) were similar between the two groups. In addition, there was no significant difference in infectious complications (40.6% vs 23.9%, P = 0.116) and noninfectious complications (31.3% vs 47.8%, P = 0.143) between the two groups. Univariate and multivariate analyses revealed that preoperative TBIL > 170 μmol/L (OR = 13.690, 95%CI: 1.275-147.028, P = 0.031), Bismuth-Corlette classification (OR = 0.013, 95%CI: 0.001-0.166, P = 0.001) and extended liver resection (OR = 14.010, 95%CI: 1.130-173.646, P = 0.040) were independent risk factors for postoperative complications.
CONCLUSION: Overall postoperative morbidity and mortality rates after major liver resection are not improved by PBD in HCCA patients with jaundice. Preoperative TBIL > 170 μmol/L, Bismuth-Corlette classification and extended liver resection are independent risk factors linked to postoperative complications.

Entities:  

Keywords:  Hilar cholangiocarcinoma; Major hepatectomy; Obstructive jaundice; Preoperative biliary drainage; Surgical outcome

Mesh:

Year:  2013        PMID: 24379593      PMCID: PMC3870521          DOI: 10.3748/wjg.v19.i46.8731

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience.

Authors:  M F Gerhards; T M van Gulik; L T de Wit; H Obertop; D J Gouma
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

2.  Segments I and IV resection as a new approach for hepatic hilar cholangiocarcinoma.

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; Y Shimizu; A Okuno; S Nozawa; Y Nukui; H Yoshitomi; N Nakajima
Journal:  Am J Surg       Date:  1998-03       Impact factor: 2.565

3.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

4.  Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.

Authors:  Y Nimura; J Kamiya; S Kondo; M Nagino; K Uesaka; K Oda; T Sano; H Yamamoto; N Hayakawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

5.  Pre-operative biliary drainage in hilar cholangiocarcinoma, benefits and risks, single center experience.

Authors:  Ehab El-Hanafy
Journal:  Hepatogastroenterology       Date:  2010 May-Jun

6.  Bile leakage and liver resection: Where is the risk?

Authors:  Lorenzo Capussotti; Alessandro Ferrero; Luca Viganò; Enrico Sgotto; Andrea Muratore; Roberto Polastri
Journal:  Arch Surg       Date:  2006-07

7.  Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).

Authors:  Sander Dinant; Michael F Gerhards; E A J Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2006-04-14       Impact factor: 5.344

8.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02

9.  Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.

Authors:  Manousos M Konstadoulakis; Sasan Roayaie; Ilias P Gomatos; Daniel Labow; Maria-Isabell Fiel; Charles M Miller; Myron E Schwartz
Journal:  Am J Surg       Date:  2008-05-07       Impact factor: 2.565

10.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

View more
  8 in total

Review 1.  Current status of preoperative biliary drainage.

Authors:  Junko Umeda; Takao Itoi
Journal:  J Gastroenterol       Date:  2015-07-03       Impact factor: 7.527

Review 2.  Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis.

Authors:  Ahmer Hameed; Tony Pang; Judy Chiou; Henry Pleass; Vincent Lam; Michael Hollands; Emma Johnston; Arthur Richardson; Lawrence Yuen
Journal:  HPB (Oxford)       Date:  2016-04-04       Impact factor: 3.647

3.  Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand.

Authors:  Attapol Titapun; Ake Pugkhem; Vor Luvira; Tharatip Srisuk; Ongart Somintara; O-Tur Saeseow; Anan Sripanuskul; Anongporn Nimboriboonporn; Bandit Thinkhamrop; Narong Khuntikeo
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

Review 4.  Resection for Klatskin tumors: technical complexities and results.

Authors:  Ivan Capobianco; Jens Rolinger; Silvio Nadalin
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-18

5.  Impact Factors for Perioperative Morbidity and Mortality and Repercussion of Perioperative Morbidity and Long-term Survival in Pancreatic Head Resection.

Authors:  Stojan Potrc; Arpad Ivanecz; Vid Pivec; Urska Marolt; Sasa Rudolf; Bojan Iljevec; Tomaz Jagric
Journal:  Radiol Oncol       Date:  2017-09-14       Impact factor: 2.991

6.  Prostaglandin E1 Preconditioning Attenuates Liver Ischemia Reperfusion Injury in a Rat Model of Extrahepatic Cholestasis.

Authors:  Feng Xu; Xiaolin Liu; Chao Wang; Chaoliu Dai
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

7.  The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: an updated meta-analysis.

Authors:  Fei Teng; You-Yin Tang; Jun-Long Dai; Yongkun Li; Zhe-Yu Chen
Journal:  World J Surg Oncol       Date:  2020-07-18       Impact factor: 2.754

8.  A New Surgical Procedure "Dumbbell-Form Resection" for Selected Hilar Cholangiocarcinomas With Severe Jaundice: Comparison With Hemihepatectomy.

Authors:  Shuguang Wang; Feng Tian; Xin Zhao; Dajiang Li; Yu He; Zhihua Li; Jian Chen
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.